Cash Flow Statement

Daily Values

Growth Metrics

Income Statement

Consolidated Net Income EBIT EBITDA EBT Equity Income Income from Continuing Operations Income from Non-Controlling Interests Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Operating Expenses Other Non Operating Income Other Operating Expenses Profit After Tax Research & Development Revenue Selling, General & Administrative Tax Provisions Tax Rate

Others

Ratios

PureTech Health (PRTC) Research & Development (2024 - 2025)

Historic Research & Development for PureTech Health (PRTC) over the last 2 years, with Q2 2025 value amounting to -$24.9 million.